Growth factor contents of autologous human sera prepared by different production methods and their biological effects on chondrocytes

Cell Biology International

Volumn 32, Issue 5, 2008, Pages 505-514

  Tanaka, Yoko ^a   Ogasawara, Toru ^a   Asawa, Yukiyo ^a   Yamaoka, Hisayo ^a   Nishizawa, Satoru ^a   Mori, Yoshiyuki ^a   Takato, Tsuyoshi ^a   Hoshi, Kazuto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autologous serum; Cartilage tissue engineering; Chondrocytes; Differentiation; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ARTICLE; CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SERUM; TISSUE ENGINEERING;

ADOLESCENT; CADHERINS; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHONDROCYTES; COLLAGEN TYPE I; COLLAGEN TYPE II; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; SERUM;

EID: 43849094043     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.12.012     Document Type: Article

References (34)

1. Atala A., Bauer S.B., Soker S., Yoo J.J., and Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367 (2006) 1241-1246
2. Bobacz K., Erlacher L., Smolen J., Soleiman A., and Graninger W.B. Chondrocyte number and proteoglycan synthesis in the aging and osteoarthritic human articular cartilage. Ann Rheum Dis 63 (2004) 1618-1622
3. Brennan M. Fibrin glue. Blood Rev 5 (1991) 240-244
4. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., and Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331 (1994) 889-895
5. Caldamone A.A., and Diamond D.A. Long-term results of the endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes. J Urol 165 (2001) 2224-2227
6. Dunham B.P., and Koch R.J. Basic fibroblast growth factor and insulinlike growth factor I support the growth of human septal chondrocytes in a serum-free environment. Arch Otolaryngol Head Neck Surg 124 (1998) 1325-1330
7. Eppley B.L., Woodell J.E., and Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 114 (2004) 1502-1508
8. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77 (1999) 527-543
9. Giannoni P., Pagano A., Maggi E., Arbico R., Randazzo N., Grandizio M., et al. Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications. Osteoarthritis Cartilage 13 (2005) 589-600
10. Gorham J.D. Transforming growth factor beta 1, Th1 responses, and autoimmune liver disease. Transfusion 45 (2005) 51S-59S
11. Guerne P.A., Blanco F., Kaelin A., Desgeorges A., and Lotz M. Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis Rheum 38 (1995) 960-968
12. Harrison P., and Cramer E.M. Platelet alpha-granules. Blood Rev 7 (1993) 52-62
13. Hermand P., Gane P., Huet M., Jallu V., Kaplan C., Sonneborn H.H., et al. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem 278 (2003) 4892-4898
14. Johnson L.F., deSerres S., Herzog S.R., Peterson H.D., and Meyer A.A. Antigenic cross-reactivity between media supplements for cultured keratinocyte grafts. J Burn Care Rehabil 12 (1991) 306-312
15. Langelier E., Suetterlin R., Hoemann C.D., Aebi U., and Buschmann M.D. The chondrocyte cytoskeleton in mature articular cartilage: structure and distribution of actin, tubulin, and vimentin filaments. J Histochem Cytochem 48 (2000) 1307-1320
16. Maes C., Stockmans I., Moermans K., Van Looveren R., Smets N., Carmeliet P., et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 113 (2004) 188-199
17. Mandl E.W., Jahr H., Koevoet J.L., van Leeuwen J.P., Weinans H., Verhaar J.A., et al. Fibroblast growth factor-2 in serum-free medium is a potent mitogen and reduces dedifferentiation of human ear chondrocytes in monolayer culture. Matrix Biol 23 (2004) 231-241
18. Marlovits S., Zeller P., Singer P., Resinger C., and Vecsei V. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol 57 (2006) 24-31
19. Meyer A.A., Manktelow A., Johnson M., deSerres S., Herzog S., and Peterson H.D. Antibody response to xenogeneic proteins in burned patients receiving cultured keratinocyte grafts. J Trauma 28 (1988) 1054-1059
20. Mizuno N., Shiba H., Ozeki Y., Mouri Y., Niitani M., Inui T., et al. Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. Cell Biol Int 30 (2006) 521-524
21. Oberlender S.A., and Tuan R.S. Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120 (1994) 177-187
22. Olney R.C., Wang J., Sylvester J.E., and Mougey E.B. Growth factor regulation of human growth plate chondrocyte proliferation in vitro. Biochem Biophys Res Commun 317 (2004) 1171-1182
23. Pardee A.B. G1 events and regulation of cell proliferation. Science 246 (1989) 603-608
24. Peterson L., Minas T., Brittberg M., and Lindahl A. Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J Bone Joint Surg Am 85-A Suppl. 2 (2003) 17-24
25. Ribault D., Khatib A.M., Panasyuk A., Barbara A., Bouizar Z., and Mitrovic R.D. Mitogenic and metabolic actions of epidermal growth factor on rat articular chondrocytes: modulation by fetal calf serum, transforming growth factor-beta, and tyrphostin. Arch Biochem Biophys 337 (1997) 149-158
26. Richmon J.D., Sage A.B., Shelton E., Schumacher B.L., Sah R.L., and Watson D. Effect of growth factors on cell proliferation, matrix deposition, and morphology of human nasal septal chondrocytes cultured in monolayer. Laryngoscope 115 (2005) 1553-1560
27. Takahashi T., Ogasawara T., Asawa Y., Mori Y., Uchinuma E., Takato T., et al. Three-dimensional microenvironments retain chondrocyte phenotypes during proliferation culture. Tissue Eng 13 (2007) 1583-1592
28. Takahashi T., Ogasawara T., Kishimoto J., Liu G., Asato H., Nakatsuka T., et al. Synergistic effects of FGF-2 with insulin or IGF-I on the proliferation of human auricular chondrocytes. Cell Transplant 14 (2005) 683-693
29. Tavella S., Raffo P., Tacchetti C., Cancedda R., and Castagnola P. N-CAM and N-cadherin expression during in vitro chondrogenesis. Exp Cell Res 215 (1994) 354-362
30. Valles J., Santos M.T., Aznar J., Martinez M., Moscardo A., Pinon M., et al. Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment. down-regulation by aspirin ex vivo. Blood 99 (2002) 3978-3984
31. Wakitani S., Imoto K., Yamamoto T., Saito M., Murata N., and Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 10 (2002) 199-206
32. Yamaoka H., Asato H., Ogasawara T., Nishizawa S., Takahashi T., Nakatsuka T., et al. Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials. J Biomed Mater Res A 78 (2006) 1-11
33. Yanaga H., Yanaga K., Imai K., Koga M., Soejima C., and Ohmori K. Clinical application of cultured autologous human auricular chondrocytes with autologous serum for craniofacial or nasal augmentation and repair. Plast Reconstr Surg 117 (2006) 2019-2030 discussion 2031-2032
34. Zelzer E., Mamluk R., Ferrara N., Johnson R.S., Schipani E., and Olsen B.R. VEGFA is necessary for chondrocyte survival during bone development. Development 131 (2004) 2161-2171